CRISPR/Cas9基因组编辑技术在农业动物中的应用

doi:10.16288/j.yczz.15-398

遗传 ›› 2016, Vol. 38 ›› Issue (3): 217-226.doi: 10.16288/j.yczz.15-398

CRISPR/Cas9基因组编辑技术在农业动物中的应用

幸宇云, 杨强, 任军

江西农业大学,省部共建猪遗传改良与养殖技术国家重点实验室,南昌330045

收稿日期:2015-09-21 修回日期:2016-01-03 出版日期:2016-03-20 发布日期:2016-03-20
通讯作者: 幸宇云,副研究员,研究方向:动物遗传育种与繁殖,动物转基因技术. E-mail:xingyuyun9@hotmail.com
基金资助:
国家科技重大专项(编号:2014ZX08006-005)和国家自然科学基金项目(编号:31560304)资助

Application of CRISPR/Cas9 mediated genome editing in farm animals

Yuyun Xing, Qiang Yang, Jun Ren

State Key Laboratory for Pig Genetic Improvement and Production Technology, Jiangxi Agricultural University, Nanchang 330045, China

Received:2015-09-21 Revised:2016-01-03 Online:2016-03-20 Published:2016-03-20
Supported by:
Supported by the National Science and Technology Major Project of China (No.2014ZX08006-005) and the National Natural Science Foundation of China (No.31560304)

摘要/Abstract

摘要： CRISPR(Clustered regularly interspaced short palindromic repeats)/Cas(CRISPR associated proteins)是在细菌和古细菌中发现的一种用来抵御病毒或质粒入侵的获得性免疫系统.目前已发现的CRISPR/Cas系统包括Ⅰ,Ⅱ和Ⅲ型,其中Ⅱ型系统的组成较简单,由其改造成的CRISPR/Cas9技术已成为一种高效的基因组编辑工具.自2013年CRISPR/Cas9技术成功用于哺乳动物基因组定点编辑以来,应用该技术进行基因组编辑的报道呈现出爆发式的增长.农业动物不仅是重要的经济动物,也是人类疾病和生物医药研究的重要模式动物.本文综述了CRISPR/Cas9技术在农业动物中的研究和应用进展,简述了该技术的脱靶效应及减少脱靶的主要方法,并展望了该技术的应用前景.

关键词: CRISPR/Cas9, 基因组编辑, 农业动物, 脱靶

Abstract: CRISPR (Clustered regularly interspaced short palindromic repeats)/Cas (CRISPR associated proteins) is an acquired immune system found in bacteria and archaea that fight against invasion of viruses or plasmids. CRISPR/Cas systems are currently classified into three main types: I, II and III, of which type II has relatively simple components. The CRISPR/Cas9 technology modified from type II CRISPR/Cas system has been developed as an efficient genome editing tool. Since the initial application of the CRISPR/Cas9 technology in mammals in 2013, the reports of this system for genomic editing has skyrocketed. Farm animals are not only economically important animals, but also ideal animal models for human diseases and biomedical studies. In this review, we summarize the applications of CRISPR/Cas9 in farm animals, briefly describe the off-target effects and the main solutions, and finally highlight the future perspectives of this technology.

Key words: CRISPR/Cas9, genome editing, farm animals, off-target

幸宇云, 杨强, 任军. CRISPR/Cas9基因组编辑技术在农业动物中的应用[J]. 遗传, 2016, 38(3): 217-226.

Yuyun Xing, Qiang Yang, Jun Ren. Application of CRISPR/Cas9 mediated genome editing in farm animals[J]. HEREDITAS(Beijing), 2016, 38(3): 217-226.

参考文献

[1] Bibikova M, Carroll D, Segal DJ, Trautman JK, Smith J, Kim YG, Chandrasegaran S. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol , 2001, 21(1): 289-297.
[2] Bibikova M, Golic M, Golic KG, Carroll D. Targeted chromosomal cleavage and mutagenesis in Drosophila using zinc-finger nucleases. Genetics , 2002, 161(3): 1169-1175.
[3] Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD. Genome editing with engineered zinc finger nucleases. Nat Rev Genet , 2010, 11(9): 636-646.
[4] Li T, Huang S, Jiang WZ, Wright D, Spalding MH, Weeks DP, Yang B. TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokI DNA-cleavage domain. Nucleic Acids Res , 2011, 39(1): 359-372.
[5] Miller JC, Tan S, Qiao GJ, Barlow KA, Wang JB, Xia DF, Meng XD, Paschon DE, Leung E, Hinkley SJ, Dulay GP, Hua KL, Ankoudinova I, Cost GJ, Urnov FD, Zhang HS, Holmes MC, Zhang L, Gregory PD, Rebar EJ. A TALE nuclease architecture for efficient genome editing. Nat Biotechnol , 2011, 29(2): 143-148.
[6] Mahfouz MM, Li LX, Shamimuzzaman M, Wibowo A, Fang XY, Zhu JK. De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks. Proc Natl Acad Sci USA , 2011, 108(6): 2623-2628.
[7] Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science , 337(6096): 816-821.
[8] 2013 Runners-Up. Genetic microsurgery for the masses. Science , 2013, 342(6165): 1434-1435.
[9] Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science , 2010, 327(5962): 167-170.
[10] Seed KD, Lazinski DW, Calderwood SB, Camilli A. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature , 2013, 494(7438): 489-491.
[11] Makarova KS, Haft DH, Barrangou R, Brouns SJ, Charpentier E, Horvath P, Moineau S, Mojica FJM, Wolf YI, Yakunin AF, van der Oost J, Koonin EV. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol , 2011, 9(6): 467-477.
[12] Zhou JW, Xu QP, Yao J, Yu SM, Cao SZ. CRISPR/Cas9 genome editing technique and its application in site-directed genome modification of animals. Hereditas (Beijing) , 2015, 37(10): 1011-1020. 周金伟, 徐绮嫔, 姚婧, 余树民, 曹随忠. CRISPR/Cas9基因组编辑技术及其在动物基因组定点修饰中的应用. 遗传, 2015, 37(10): 1011-1020.
[13] Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J. RNA- programmed genome editing in human cells. Elife , 2013, 2: e00471.
[14] Cong L, Ann Ran F, Cox D, Lin SL, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA, Zhang F. Multiplex genome engineering using CRISPR/Cas systems. Science , 2013, 339(6121): 819-823.
[15] Mali P, Yang LH, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM. RNA-guided human genome engineering via Cas9. Science , 2013, 339(6121): 823-826.
[16] Lu XJ, Xue HY, Ke ZP, Chen JL, Ji LJ. CRISPR-Cas9: a new and promising player in gene therapy. J Med Genet , 2015, 52(5): 289-296.
[17] Shalem O, Sanjana NE, Zhang F. High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet , 2015, 16(5): 299-311.
[18] Feng WY, Dai YF, Mou LS, Cooper DKC, Shi DS, Cai ZM. The potential of the combination of CRISPR/Cas9 and pluripotent stem cells to provide human organs from chimaeric pigs. Int J Mol Sci , 2015, 16(3): 6545-6556.
[19] Hai T, Teng F, Guo RF, Li W, Zhou Q. One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Res , 2014, 24(3): 372-375.
[20] Zhou XQ, Xin JG, Fan NN, Zou QJ, Huang J, Ouyang Z, Zhao Y, Zhao BT, Liu ZM, Lai SS, Yi XL, Guo L, Esteban MA, Zeng YZ, Yang HQ, Lai LX. Generation of CRISPR/ Cas9-mediated gene-targeted pigs via somatic cell nuclear transfer. Cell Mol Life Sci , 2015, 72(6): 1175-1184.
[21] Honda A, Hirose A, Sankai T, Yasmin L, Yuzawa K, Honsho K, Izu H, Iguchi A, I

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

CRISPR/Cas9基因组编辑技术在农业动物中的应用

Application of CRISPR/Cas9 mediated genome editing in farm animals

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	廉小平, 黄光福, 张玉娇, 张静, 胡凤益, 张石来. 长雄野生稻有利基因的发掘与利用[J]. 遗传, 2023, 45(9): 765-780.
[2]	王秉政, 张超, 张佳丽, 孙锦. 利用单转录本表达Cas9和sgRNA条件性编辑果蝇基因组[J]. 遗传, 2023, 45(7): 593-601.
[3]	刘梅珍, 王立人, 李咏梅, 马雪云, 韩红辉, 李大力. 利用CRISPR/Cas9技术构建基因编辑大鼠模型[J]. 遗传, 2023, 45(1): 78-87.
[4]	张潇筠, 徐坤, 沈俊岑, 穆璐, 钱泓润, 崔婕妤, 马宝霞, 陈知龙, 张智英, 魏泽辉. 一种新型提高HDR效率的CRISPR/Cas9-Gal4BD供体适配基因编辑系统[J]. 遗传, 2022, 44(8): 708-719.
[5]	张充, 魏子璇, 王敏, 陈瑶生, 何祖勇. 利用CRISPR/Cas9在人类黑色素瘤细胞中编辑MC1R与功能分析[J]. 遗传, 2022, 44(7): 581-590.
[6]	刘尧, 周先辉, 黄舒泓, 王小龙. 引导编辑：突破碱基编辑类型的新技术[J]. 遗传, 2022, 44(11): 993-1008.
[7]	韩玉婷, 许博文, 李羽童, 卢心怡, 董习之, 邱雨浩, 车沁耘, 朱芮葆, 郑丽, 李孝宸, 司绪, 倪建泉. 模式动物果蝇的基因调控前沿技术[J]. 遗传, 2022, 44(1): 3-14.
[8]	杨光武, 田嫄. 果蝇F-box基因Ppa促进脂肪储存[J]. 遗传, 2021, 43(6): 615-622.
[9]	彭定威, 李瑞强, 曾武, 王敏, 石翾, 曾检华, 刘小红, 陈瑶生, 何祖勇. 编辑MSTN半胱氨酸节基元促进两广小花猪肌肉生长[J]. 遗传, 2021, 43(3): 261-270.
[10]	王娜, 甲芝莲, 吴强. RFX5调控原钙粘蛋白α基因簇的表达[J]. 遗传, 2020, 42(8): 760-774.
[11]	李国玲, 杨善欣, 吴珍芳, 张献伟. 提高CRISPR/Cas9介导的动物基因组精确插入效率研究进展[J]. 遗传, 2020, 42(7): 641-656.
[12]	陈赢男, 陆静. CRISPR/Cas9系统在林木基因编辑中的应用[J]. 遗传, 2020, 42(7): 657-668.
[13]	田菁, 王宇哲, 闫世雄, 孙帅, 贾俊静, 胡晓湘. 代谢组学技术发展及其在农业动植物研究中的应用[J]. 遗传, 2020, 42(5): 452-465.
[14]	刘思远, 易国强, 唐中林, 陈斌. 基于CRISPR/Cas9系统在全基因组范围内筛选功能基因及调控元件研究进展[J]. 遗传, 2020, 42(5): 435-443.
[15]	鲍莉雯, 周一叶, 曾凡一. 基于CRISPR/Cas9技术的β-地中海贫血和血友病基因治疗研究进展[J]. 遗传, 2020, 42(10): 949-964.